Veekayem Fash. (VEEKAYEM)
TurnaroundScore breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹208.95 |
| Market Cap | ₹122.77 Cr |
| P/E Ratio | 11.06 |
| ROCE | 14.05% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 7.07% |
| Debt/Equity | — |
| Sales Growth | -19.75% |
| Promoter Holding | 73.61% |
| 52-Week Range | ₹79.8 — ₹315 |
| Sector | Textiles & Apparels |
Strengths
- Low P/E of 11.06 with positive profit growth of 7.07%
- ROCE of 14.05% indicates reasonable capital efficiency
- High promoter holding of 73.61% aligns interests with minority shareholders
- Piotroski F-Score of 6/9 suggests moderate financial health
- Latest quarter profitable with ₹3 crore net profit on ₹98 crore sales
Concerns
- Sales growth sharply negative at -19.75%, showing significant top-line weakness
- Profit growth without sales growth may be unsustainable if driven by cost cuts
- No dividend, so investors get no income while waiting for a recovery
- Missing book value, ROE, and debt-equity data limits a full Graham-style valuation
AI Analysis
Veekayem Fashions is a small-cap garment player caught in a tricky phase. At ₹142, the market cap is just ₹87 crore, and the P/E is 11.06. That looks cheap, but I always remind myself: cheap can become cheaper if the business fundamentals keep eroding. Sales fell nearly 20%; that is a red flag. In garments, top-line shrinkage often means lost orders, weak demand, or pricing pressure. Profit rose 7.07%, which is interesting, but I treat bottom-line growth without sales growth with suspicion. It may come from better operating efficiency or cost control—both finite. ROCE at 14.05% is respectable; it suggests capital is not being destroyed. A Piotroski score of 6 out of 9 gives some comfort on financial health, but we lack book value, ROE, and debt-equity data. As Graham would say, you cannot value what you cannot measure. Promoter holding at 73.61% is strong and signals skin in the game, but it also leaves a thin floating stock and potential volatility. There is no dividend, so shareholders depend entirely on price appreciation. The stock has collapsed from ₹318 to ₹142—a huge fall; value may be emerging, but the falling knife risk remains. The latest quarter shows ₹98 crore in sales and ₹3 crore net profit; margins are thin. This looks more like a turnaround situation than a durable compounder. I need sustained sales recovery and margin stability before committing. If management can restore growth, the low P/E makes it interesting, but I will not pay for hopes alone.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer